These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27478867)

  • 1. Mycobacterial Protein Tyrosine Phosphatases A and B Inhibitors Augment the Bactericidal Activity of the Standard Anti-tuberculosis Regimen.
    Dutta NK; He R; Pinn ML; He Y; Burrows F; Zhang ZY; Karakousis PC
    ACS Infect Dis; 2016 Mar; 2(3):231-239. PubMed ID: 27478867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Targeting of Protein Tyrosine Phosphatases from
    Ruddraraju KV; Aggarwal D; Zhang ZY
    Microorganisms; 2020 Dec; 9(1):. PubMed ID: 33374544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.
    de Knegt GJ; ten Kate MT; van Soolingen D; Aarnoutse R; Boeree MJ; Bakker-Woudenberg IA; de Steenwinkel JE
    Tuberculosis (Edinb); 2014 Dec; 94(6):701-7. PubMed ID: 25621361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Insight into MptpB Inhibitors as a Key Strategy to Treat MDR and XDRTuberculosis.
    Jain M; Gollapudi S; Khatik GL
    Curr Pharm Des; 2023; 29(8):562-575. PubMed ID: 36892024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium tuberculosis Low Molecular Weight Phosphatases (MPtpA and MPtpB): From Biological Insight to Inhibitors.
    Fanzani L; Porta F; Meneghetti F; Villa S; Gelain A; Lucarelli AP; Parisini E
    Curr Med Chem; 2015; 22(27):3110-32. PubMed ID: 26264920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New strategies in fighting TB: targeting Mycobacterium tuberculosis-secreted phosphatases MptpA & MptpB.
    Silva AP; Tabernero L
    Future Med Chem; 2010 Aug; 2(8):1325-37. PubMed ID: 21426021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of fusarielin M as a novel inhibitor of Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB).
    Chen D; Liu L; Lu Y; Chen S
    Bioorg Chem; 2021 Jan; 106():104495. PubMed ID: 33293055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.
    de Knegt GJ; Ten Kate MT; van Soolingen D; Aarnoutse R; Boeree MJ; Bakker-Woudenberg IA; de Steenwinkel JE
    Tuberculosis (Edinb); 2014 Oct; ():. PubMed ID: 25423883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of MptpB phosphatase from Mycobacterium tuberculosis impairs mycobacterial survival in macrophages.
    Beresford NJ; Mulhearn D; Szczepankiewicz B; Liu G; Johnson ME; Fordham-Skelton A; Abad-Zapatero C; Cavet JS; Tabernero L
    J Antimicrob Chemother; 2009 May; 63(5):928-36. PubMed ID: 19240079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and evaluation of novel inhibitors of mycobacterium protein tyrosine phosphatase B from the 6-Hydroxy-benzofuran-5-carboxylic acid scaffold.
    He Y; Xu J; Yu ZH; Gunawan AM; Wu L; Wang L; Zhang ZY
    J Med Chem; 2013 Feb; 56(3):832-42. PubMed ID: 23305444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
    Wada M
    Kekkaku; 2001 Jan; 76(1):33-43. PubMed ID: 11211781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tedizolid, Faropenem, and Moxifloxacin Combination With Potential Activity Against Nonreplicating
    Srivastava S; Cirrincione KN; Deshpande D; Gumbo T
    Front Pharmacol; 2020; 11():616294. PubMed ID: 33542690
    [No Abstract]   [Full Text] [Related]  

  • 16. Targeting Drug-Sensitive and -Resistant Strains of Mycobacterium tuberculosis by Inhibition of Src Family Kinases Lowers Disease Burden and Pathology.
    Chandra P; Rajmani RS; Verma G; Bhavesh NS; Kumar D
    mSphere; 2016; 1(2):. PubMed ID: 27303736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SILA-421 activity in vitro against rifampicin-susceptible and rifampicin-resistant Mycobacterium tuberculosis, and in vivo in a murine tuberculosis model.
    de Knegt GJ; Bakker-Woudenberg IA; van Soolingen D; Aarnoutse R; Boeree MJ; de Steenwinkel JE
    Int J Antimicrob Agents; 2015 Jul; 46(1):66-72. PubMed ID: 25951996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium tuberculosis and its secreted tyrosine phosphatases.
    Chatterjee A
    Biochimie; 2023 Sep; 212():41-47. PubMed ID: 37059349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrazinamide resistance in Mycobacterium tuberculosis: Review and update.
    Njire M; Tan Y; Mugweru J; Wang C; Guo J; Yew W; Tan S; Zhang T
    Adv Med Sci; 2016 Mar; 61(1):63-71. PubMed ID: 26521205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.